Swiss National Bank Sells 600 Shares of Integer Holdings Co. (NYSE:ITGR)

Swiss National Bank lowered its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 0.9% in the 3rd quarter, HoldingsChannel reports. The firm owned 65,400 shares of the medical equipment provider’s stock after selling 600 shares during the period. Swiss National Bank’s holdings in Integer were worth $8,502,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of ITGR. Contravisory Investment Management Inc. boosted its stake in Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 80 shares in the last quarter. Xponance Inc. increased its position in Integer by 4.9% in the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock valued at $245,000 after buying an additional 99 shares in the last quarter. Azzad Asset Management Inc. ADV raised its stake in Integer by 0.9% during the 3rd quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock worth $1,504,000 after buying an additional 107 shares during the period. GAMMA Investing LLC boosted its holdings in Integer by 60.9% in the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after acquiring an additional 142 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its stake in Integer by 3.6% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock valued at $689,000 after acquiring an additional 205 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ITGR. Bank of America upped their target price on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. Piper Sandler reaffirmed an “overweight” rating and set a $140.00 target price (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Citigroup upped their target price on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. Benchmark upped their target price on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. Finally, Truist Financial lowered their target price on Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $139.75.

Integer Stock Performance

ITGR stock opened at $140.30 on Tuesday. The business has a 50 day moving average of $130.46 and a 200-day moving average of $123.76. The firm has a market cap of $4.71 billion, a PE ratio of 43.30, a P/E/G ratio of 1.98 and a beta of 1.09. Integer Holdings Co. has a 12-month low of $84.75 and a 12-month high of $141.27. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.27 EPS. As a group, sell-side analysts expect that Integer Holdings Co. will post 5.34 earnings per share for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.